About Rho(D) Immune Globulin Dosing

This Rho(D) Immune Globulin (RhoGAM) dose calculator provides guidance for determining the appropriate dosage to prevent Rh alloimmunization in Rh-negative pregnant women. It is intended for educational purposes and should be used in conjunction with clinical judgment and institutional protocols. Rho(D) immune globulin works by preventing an Rh-negative mother from forming antibodies against Rh-positive fetal red blood cells that may have entered her bloodstream, which could cause hemolytic disease of the fetus and newborn (HDFN) in subsequent pregnancies.

Outputs Explained

After entering the required clinical information, the calculator will provide the following outputs:

• Recommended Dosing: The total dose in micrograms (mcg) and the number of vials required. This will specify whether a standard-dose (300 mcg) or micro-dose (50 mcg) is needed.
• Dosing Summary: A clear statement summarizing the administration instructions based on the selected scenario.
• Calculation Breakdown: For cases involving Fetal-Maternal Hemorrhage (FMH), an expandable section shows the step-by-step calculation, including the estimated fetal blood volume and the rounding logic used to determine the final vial count.

How to Use the Calculator

Follow these steps to determine the recommended Rho(D) immune globulin dose:

1. Select Clinical Scenario: Choose the option that best describes the clinical situation, such as routine 28-week prophylaxis, a sensitizing event at a specific gestation, or a confirmed/suspected large fetal-maternal hemorrhage.
2. Enter FMH Test Results (if applicable): If you select the postpartum or large hemorrhage scenario, you must provide results from a quantitative test.
   • For a Kleihauer-Betke (KB) test, enter the result as a percentage of fetal cells.
   • For Flow Cytometry, enter the result in milliliters (mL) and specify if it represents fetal whole blood or just fetal red blood cells (RBCs).
3. Provide Maternal Blood Volume (optional): For KB test calculations, the calculator uses a default maternal blood volume of 5000 mL. You can enter a different value for a more precise calculation if known.
4. Calculate Dose: Click the "Calculate Dose" button to see the results.

Dosing Overview

Dosing is based on the volume of fetal blood exposure and the gestational age at which a sensitizing event occurs.

• Routine Antenatal Prophylaxis: One standard 300 mcg dose is administered at 28 weeks' gestation.
• Events < 13 Weeks Gestation: One micro-dose of 50 mcg is sufficient for events in the first trimester (e.g., spontaneous or induced abortion).
• Events ≥ 13 Weeks Gestation: One standard 300 mcg dose is recommended for sensitizing events at or after 13 weeks.
• Postpartum / Large FMH: The dose is calculated based on the estimated volume of hemorrhage. One 300 mcg vial neutralizes up to 30 mL of Rh-positive fetal whole blood (or 15 mL of fetal RBCs). The calculation includes a safety margin to ensure adequate coverage.

Switching Products

This calculator provides a dose in micrograms, which is standard across different brands of Rho(D) immune globulin. However, products may vary in formulation (e.g., intramuscular vs. intravenous) and concentration. "Switching" is not typically applicable as this is not a long-term maintenance therapy. Always follow the specific administration instructions for the product being used and adhere to institutional guidelines.

Missed Dose

Rho(D) immune globulin should be administered within 72 hours of any potential sensitizing event for maximum efficacy. If more than 72 hours have passed, the dose should be given as soon as possible, as it may still provide some protection. Consult an obstetrician or maternal-fetal medicine specialist for guidance in cases of delayed administration.

Safety Alerts

Frequently Asked Questions (FAQ)

Why does the FMH calculation add an extra "safety" vial?

This is a standard practice recommended by ACOG and product manufacturers to account for the inherent imprecision of quantitative tests like the Kleihauer-Betke assay. The safety vial ensures that a sufficient dose is given to prevent alloimmunization even if the fetal hemorrhage was slightly underestimated.

How does the calculator handle rounding for FMH vials?

The calculator determines the number of vials needed based on the estimated fetal bleed. If the decimal portion of the calculated vials is less than 0.5, it rounds down and adds one safety vial. If the decimal is 0.5 or greater, it rounds up and adds one safety vial.

How much fetal blood does one standard 300 mcg vial cover?

One standard-dose 300 mcg vial is sufficient to prevent alloimmunization from an exposure of up to 30 mL of Rh-positive fetal whole blood or 15 mL of fetal red blood cells (RBCs).

The Flow Cytometry test reported fetal RBCs. How does the calculator convert this to whole blood?

The calculator assumes that fetal red blood cells constitute approximately half the volume of fetal whole blood. Therefore, it multiplies the volume of fetal RBCs by 2 to estimate the total fetal whole blood volume before calculating the required dose.

What is the default Maternal Blood Volume (MBV) used?

The calculator uses a default MBV of 5000 mL, a standard assumption for a term pregnancy. This value is used in the Kleihauer-Betke formula to convert the percentage of fetal cells into a milliliter volume.

What's the difference between a "micro-dose" and a "standard-dose" vial?

A micro-dose vial contains 50 mcg of Rho(D) immune globulin and is used for events during the first trimester. A standard-dose vial contains 300 mcg and is used for routine 28-week prophylaxis, postpartum administration, and events after the first trimester.

Can this calculator be used for Rh-positive mothers?

No. Rho(D) immune globulin is only indicated for Rh-negative individuals to prevent the development of anti-D antibodies. It is contraindicated in those who are already Rh-positive.

What are some examples of "sensitizing events"?

Events that can cause fetal blood to enter the maternal circulation include miscarriage, abortion, ectopic pregnancy, amniocentesis, chorionic villus sampling (CVS), abdominal trauma, external cephalic version, and delivery.

References

• RhoGAM® Ultra-Filtered PLUS [prescribing information]. Kedrion Biopharma Inc. Retrieved from the FDA Online Label Repository.
• American College of Obstetricians and Gynecologists. (2017). ACOG Practice Bulletin No. 181: Prevention of Rh D Alloimmunization. Obstetrics & Gynecology, 130(2), e57-e70.
• Moise, K. J., Jr. (2023). Prevention of Rh(D) alloimmunization in Rh(D)-negative women. In T. A. Barss (Ed.), UpToDate. Retrieved October 26, 2023.
• U.S. Food and Drug Administration. (n.d.). Drugs@FDA: FDA-Approved Drugs. https://www.accessdata.fda.gov/scripts/cder/daf/